Moreover, high CD44 expression was also found in low-grade glioma and glioblastoma tissues compared to normal brain tissues, with the CD44 expression level serving as a predictive marker for OS rate in low-grade glioma patients [187]. This evidence concerns the gene CD44 and central nervous system cancer.